BioNova Pharma develops biopharmaceutical treatments targeting cancer through advanced drug formulation and delivery methods. The company focuses on addressing the unmet medical needs of patients with various cancer types by enhancing therapeutic efficacy and minimizing side effects.
Funding
$25M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many cancer treatments face challenges in effectively targeting tumor cells while minimizing damage to healthy tissues, leading to significant side effects and reduced therapeutic efficacy. Traditional drug formulations may also have limited bioavailability, hindering their ability to reach the tumor site in sufficient concentrations.
Solution
BioNova Pharma develops biopharmaceutical treatments for cancer using advanced drug formulation and targeted delivery methods. The company focuses on enhancing therapeutic efficacy and reducing side effects by improving drug bioavailability and selectively targeting cancer cells. Their approach aims to address the unmet medical needs of patients with various cancer types through innovative pharmaceutical solutions.
Target Audience
The primary target audience includes patients with various cancer types, oncologists, and healthcare providers seeking more effective and less toxic treatment options.
Features
- Pipeline of novel drug candidates (BN104, BN105) targeting various cancer types.
- Advanced drug formulation techniques to improve bioavailability and stability.
- Targeted drug delivery systems designed to selectively deliver therapeutic agents to tumor cells.
- Focus on minimizing off-target effects and reducing treatment-related toxicities.